Back to search

France· FR:65262139

FAMPRIDINE VIATRIS LP 10 mg, comprimé à libération prolongée

A fampridine product containing fampridine, registered in France by VIATRIS SANTE, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC N07XX07

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedFAMPRIDINE VIATRIS LP 10 mg, comprimé…ATCN07XX07REGISTER NO.FR:65262139PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Fampridine is registered in 15 of 19 countries.

Countries holding a registration under ATC N07XX07 (fampridine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 8 of them publish a price we can compare per daily dose

Fampridine · ATC N07XX07

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fampridine costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $2.00 in France to $11.20 in Switzerland — a ×5.6 gap.

  • France: $2.00 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Fampridine · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$11.20
  • FR France$2.00
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
FAMPRIDINE
Manufacturer
VIATRIS SANTE
Country
France (FR)
ATC code
N07XX07
ATC class
Fampridine
Defined daily dose
20 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400930242230
    plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 28 comprimé(s)
    EUR 24.61
  • cip13
    3400930242247
    plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 56 comprimé(s)
    EUR 48.82

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

32 interactions on record for fampridine.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fampridine · interactions on record

32 records

  • 4 severe
  • 28 moderate

Most severe, free to view

  • BupropionN06AX12severe
  • BupropionN07BA02severe
  • IohexolV08AB02severe
  • IopamidolV08AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fampridine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fampridine products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Fampridin Neuraxpharm, Fampridin Ratiopharm
  • Cyprus · Fampridine Sandoz, Fampridine Viatris
  • Czechia · Fampridin Sandoz, Fampridine Abdi
  • Germany · Fampridin Abdi, Fampridin Abz
  • Denmark · Fampridin "neuraxpharm", Fampridin Medical Valley
  • Spain · Fampridina Aurovitas, Fampridina Qualigen
  • Finland · Fampridin Medical Valley, Fampridin Zentiva
  • United Kingdom (Northern Ireland) · Elupria, Fampridine Abdi
  • Greece · Fadisa, Fampridine Sandoz
  • Croatia · Fampridin Sandoz, Fampridin Teva
  • Hungary · Fampridine Rontis
  • Ireland · Fampridine Rowa
  • Iceland · Fampridin Medical Valley, Fampridin Neuraxpharm
  • Italy · Fampridina Abdi
  • Liechtenstein · Fampridine Accord, Fampyra
  • Luxembourg · Fampridine Eg
  • Malta · Fampridine Viatris
  • Netherlands · Fampridine Abdi, Fampridine Ascend
  • Norway · Fampridin Medical Valley, Fampridin Neuraxpharm
  • Poland · Fampridine Sandoz, Fampridine Teva
  • Portugal · Fampridina Ascend, Fampridina Generis
  • Sweden · Fampridin Medical Valley, Fampridin Zentiva
  • Slovenia · Fampridin Stada, Fampridin Teva
  • Slovakia · Fampridín Teva, Fampridine Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1dede7aa-cd2c-4b3b-8fae-563517d14d6c
GET /v1/drugs/1dede7aa-cd2c-4b3b-8fae-563517d14d6c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65262139",
  "date_amm": "2021-11-19",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "FAMPRIDINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé à libération prolongée",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about fampridine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.